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RESUMO
Introdução: A hipocalcemia é uma complicação frequente após tiroidectomia total e o principal motivo pelo internamento prolongado 
destes doentes.
Material e Métodos: Estudaram-se prospectivamente 112 doentes submetidos a tiroidectomia total ou restante entre Junho de 2012 
e Novembro de 2013. Foram excluídos 12 casos por apresentarem alterações pré-operatórias da função da paratiróide. Doseou-se a 
paratormona e cálcio pré-operatórios, imediatamente após a cirurgia, no primeiro dia e no 14º dia após a cirurgia. 
Resultados: Dos 100 doentes incluídos 60 desenvolveram hipocalcemia (60%), revelando-se sintomática em 14. Surgiu, maioritari-
amente, 24 horas após a cirurgia (76,7%). Foi definitiva em três doentes e transitória nos restantes. Nos 60 doentes com hipocalcemia, 
verificou-se hipoparatiroidismo em 19 doentes no doseamento imediatamente após a cirurgia, 14 no doseamento no primeiro dia mas 
apenas três mantiveram hipoparatiroidismo após 14 dias (doentes com hipocalcemia definitiva). Comparando o grupo de doentes com 
e sem hipocalcemia constatou-se uma diminuição da paratormona em ambos (imediatamente após a cirurgia e no primeiro dia) mas 
foi mais importante no grupo com hipocalcemia (p = 0,004 e p < 0,001). O decréscimo da paratormona foi mais acentuado no grupo 
com hipocalcemia, com maior significado no primeiro dia (50,29% vs 22,47% - p < 0,001). O melhor factor preditivo de hipocalcemia 
identificado foi o decréscimo da paratormona no primeiro dia após a cirurgia > 19,4% (sensibilidade = 82%; especificidade = 63%). 
Discussão: No nosso estudo verificou-se uma incidência elevada de hipocalcemia (60%), que se manifestou maioritariamente 24 
horas após a cirurgia e que condicionou, nesses doentes, um tempo de internamento mais prolongado. No entanto, em apenas três 
doentes (3%) a hipocalcemia foi definitiva. Constatou-se ainda uma correspondência na oscilação dos valores séricos do cálcio e da 
paratormona que permitiu identificar o decréscimo da paratormona no primeiro dia após a cirurgia como um fiável factor predictivo de 
hipocalcemia.
Conclusão: O decréscimo da paratormona no primeiro dia após a cirurgia > 19,4% é um bom factor preditivo de hipocalcemia após 
tiroidectomia total/restante, permitindo identificar os doentes com maior risco, medicá-los profilaticamente e obter altas precoces e 
seguras.
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ABSTRACT
Introduction: Hypocalcemia is a frequent complication after total thyroidectomy and the main reason for prolonged hospitalization of 
these patients.
Material and Methods: We studied prospectively 112 patients who underwent total or completation thyroidectomy between June 2012 
and November 2013. Twelve patients with preoperative changes in parathyroid function were excluded. Parathyroid hormone and 
calcium levels were determined pre-operatively, immediately after surgery, on 1st day and on 14th day after surgery.
Results: Of the 100 patients enrolled, 60 have developed hypocalcaemia (60%) but only 14 patients had symptomatic hypocalcaemia. 
It mostly occurs 24 hours after surgery (76.7%). It was permanent in 3 patients and temporary in the others. In the 60 patients with 
hypocalcaemia, it has been found hypoparathyroidism in 19 patients immediately after surgery, in 14 patients on 1st day but only 3 had 
hypoparathyroidism (patients with permanent hypocalcaemia). Comparing the group of patients with and without hypocalcaemia we 
found a decrease of parathyroid hormone in both (immediately after surgery and on 1st day) but was more important in the hypocalcaemia 
group (p = 0.004 and p < 0.001). The decrease of PTH levels was more pronounced in the hypocalcaemia group, with significance on 
the first day (22.29% vs 50.29%, p < 0.001). The best predictor of hypocalcaemia identified was the decrease of parathyroid hormone 
levels > 19.4% determined on the 1st day (sensitivity = 82%; specificity = 63%).
Discussion: In our study there was a high incidence of hypocalcemia (60%), expressed predominantly 24 hours after surgery and 
conditioned, in these patients, a longer hospital stay. However, only 3 patients (3%) had permanent hypocalcemia. We still found a 
match in the oscillation of serum calcium levels and parathyroid hormone which identified the decrease in parathyroid hormone on the 
first day after surgery as a reliable predictor of hypocalcemia.
Conclusion: Decrease of parathyroid hormone levels > 19.4% determined on 1st day is a good predictor of hypocalcemia after total /
completation thyroidectomy, allowing to identify patients at higher risk of hypocalcemia, medicate them prophylactically and get early 
and safe discharges.
Keywords: Hypocalcemia; Parathyroid Hormone; Postoperative Period; Thyroidectomy.
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INTRODUCTION
 Hypocalcaemia (HPC) is one of the most frequent 
complications after total thyroidectomy.1-8 Its incidence 
varies between 20 to 50%2,4,10,11 and despite its multifactorial 
aetiology, most cases are associated to secondary 
hypoparathyroidism related to excision, injury or parathyroid 
gland iatrogenic de-vascularization during surgery.2 
 Post-thyroidectomy HPC is usually temporary, a 
permanent disorder occurring in 2% of patients.3,4
 Unlike other post-thyroidectomy complications occurring 
on the first 24 hours (vocal cord paralysis, laryngeal 
oedema, bruising), HPC typically occurs between 24 to 
48 hours after surgery.2 This delayed manifestation, found 
in patients who undergo total thyroidectomy, is the major 
cause for longer hospital stays, allowing for blood calcium 
concentrations and possible clinical manifestations of 
HPC to be monitored.2 Many strategies are followed in the 
diagnosis and treatment of HPC. The traditional method 
includes serial blood calcium determinations in the first 48 
hours after surgery, still used in several hospitals worlwide,5-7 
including ours. Some recommend routine oral calcium and 
vitamin D supplementation in patients who undergo total 
thyroidectomy, allowing for short-term hospital stays and 
minimizing the risk of HPC upon discharge.8 In the last few 
years, some studies have actually suggested parathyroid 
hormone (PTH) determination upon thyroidectomy as a 
predictive factor of the risk of HPC.1,2,9-12,23-30 This test may 
have an important role in the identification of patients at 
a higher risk of post-thyroidectomy HPC and therefore 
assisting the surgeon’s decision regarding the need to 
maintain hospital monitoring or instead, to use a calcium 
+ vitamin D supplementation according to short-term blood 
calcium monitoring (< 24 hours upon surgery).13
 Different protocols of PTH assessment as a HPC 
predictive factor post thyroidectomy have been described. 
Beyond pre-surgery determination of patient’s basal level, 
different post-surgery assessments are used: immediately 
upon surgery, six-hour, 24-hour and even 48-hours 
postsurgery.14 Regardless of the time of PTH determination, 
its concentration or  decrease from basal level have both 
been shown to be as good for predicting HPC after total/
remnant thyroidectomy.14
MATERIAL AND METHODS
 This was a prospective study involving all patients 
submitted to total (TT) or remnant (RT) thyroidectomy 
between June 2012 and November 2013 at the Surgical 
Department B of the Centro Hospitalar e Universitário 
de Coimbra. Patients presenting with any pre-operative 
parathyroid gland disorder, chronic kidney failure (serum 
creatinine > 2 mg/dl or creatinine clearance < 40 ml/
min) or any disease/therapy interfering with calcium 
homeostasis were excluded. From the 112 patients that 
were assessed, 12 were excluded due to the presence 
of one of the abovementioned exclusion criteria. The 100 
patients included in the study (88 females) had on average 
47.9 years of age (range: 24-80). Most patients underwent 
total thyroidectomy (87%) and the presence of multinodular 
goitre was the most frequent surgical indication (45%). 
Other surgical indications included the presence of thyroid 
nodules with follicular (20%) or papillary carcinoma (22%) 
cytology. Patients who underwent remnant thyroidectomy 
related to thyroid carcinomas found in previous lobectomies 
(13%) were also included, as the risk of HPC and 
hypoparathyroidism (HPT) in these patients overlaps the 
risk of patients who underwent total thyroidectomy. On 
average three parathyroid glands (minimum 1; maximum 
4) were identified during surgery. Parathyroid glands 
(subcapsular or intra-parenchymal) were identified in eight 
patient’s pathological specimens.
 Patient’s pre-operative basal PTH and blood calcium 
levels were obtained together with immediate post-operative 
PTH levels (PTH0), as well as calcium concentrations 
six-hours,  on the first and 14th day (PTH1, PTH14) post-
surgery. Phosphate and magnesium levels were also 
obtained together with calcium levels due to the importance 
of these two ions on calcium homeostasis (Table 1). The 
proportional immediate post-surgical decrease in PTH 
levels (PTH0) and on the first post-operative day (PTH1) 
were calculated using the formula: (pre-op PTH – post-op 
PTH) x 100 /pre-op PTH). 
 PTH levels were obtained by use of immunochemical 
luminescent assay labelled with acridine ester – CENTAUR 
(Siemens). 
 HPC and HPT were considered when blood calcium 
and serum PTH levels were below 8.8 mg/dL and 9 pg/
mL, respectively. Phosphate levels between 2.5 – 4.5 mg/
dL and magnesium levels between 1.8-2.5 mg/dL were 
considered as normal. Transitory HPC was considered 
when it resolved within 12 months upon surgery, with no 
need for oral calcium supplementation to be maintained. 
Table 1 - Lab-tests included in our study
Pre-operative PTH, Calcium, Phosphate, Magnesium
Upon surgery PTH
6-hours post-surgery Calcium, Phosphate, Magnesium
1st POD PTH, Calcium, Phosphate, Magnesium
14th POD PTH, Calcium, Phosphate, Magnesium
PTH: Parathyroid hormone; POD: Post-operative day. 
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HPC was considered permanent when it persisted after 12 
months, requiring oral calcium supplementation.
 Statistical analysis used SPSS version 20.0 software. 
Comparison between groups – patients with HPC vs. 
patients with normocalcaemia (NC) – was established using 
the Mann-Whitney’s, Student’s t, U and chi-square tests. 
A level of significance of p< 0.05 was established. Areas 
under the ROC (receiver operating characteristic) curves 
were estimated in order to calculate the predictive power of 
PTH measurement.
RESULTS 
 From the 100 patients that underwent TT or RT, 60 
developed HPC (60%). However, HPC was symptomatic in 
only 14 patients (14/60 or 23.3%) with the need for calcium 
and vitamin D supplementation. Blood calcium levels 
remained normal during the entire post-operative period in 
40 of the 100 patients.
 A 2.67 post-operative days (POD) average hospital stay 
was found in the 100 patients and was higher in the HPC 
group (2.93 POD vs. 2.27 POD). A 4.21 POD hospital stay 
for symptomatic HPC patients was also found, significantly 
higher than in the remaining patients.
 All the 100 patients showed a decreased calcium level 
both at 6-hours post-surgery and on the first day upon 
surgery, although the latter was higher in HPC patients (p 
< 0.001) (Table 2). HPC was found, in most patients, 24 
hours upon surgery (76.7%) and was transitory in almost 
all patients – 97% (confirmed on the 14th POD), with only 
three patients presenting with definitive HPC (confirmed on 
the 14th POD and on the 6th and 12th month upon surgery), 
requiring sustained calcium and vitamin D supplementation 
after  the 14th POD.
 As regards phosphate and magnesium monitoring, 
an inversely proportional relationship was found between 
phosphate and calcium levels and the highest phosphate 
levels were found in the HPC group of patients [HPC 
group: phosphate = 4.2 mg/dL (3.3 – 5.7) versus NC group: 
phosphate = 3.5 mg/dL (2.6 – 4.4), p = 0.24]; magnesium 
levels remained within the normal range, with no statistically 
significant differences between NC [magnesium = 2.1 mg/
dL (1.8 – 2.4)] and HPC groups [magnesium = 2.2 mg/dL 
(1.8 – 2.5)]. When comparing HPC (n = 60) to NC patients (n 
= 40), a reduction in serum PTH levels was found in both (in 
immediate post-surgery as in 24-hour upon surgery). This 
reduction was higher in the HPC group (p = 0.004 and p < 
0.001 respectively) (Table 3). Only three patients were found 
with HPT on the 14th POD determination, corresponding to 
the patients with definitive HPC. A new PTH determination 
was obtained at the 6th and the 12th month upon surgery 
in these three patients and remained below normal levels, 
therefore confirming definitive HPT (Fig. 1).
 The presence of HPT was found in 19 patients in the 
immediate post-surgical determination in HPC patients 
(n = 60). Only 14 maintained PTH levels below 9 pg/mL 
after the first 24-hours (corresponding to the 14 patients 
with symptomatic HPC that needed calcium and vitamin 
D outpatient supplementation) (Fig. 1 and 2). However, 
Table 2 - Patients with definitive HPC
Patient 1 Patient 2 Patient 3
Nº Parathyroid glands identified during surgery 2 2 2
Nº Parathyroid identified in pathological examination 1 1 2
Table 3 - Average PTH and blood calcium levels in the 100 patients submitted to total or remnant thyroidectomy
Total / Remnant thyroidectomy n = 100
Normocalcaemia
n = 40
Hypocalcaemia
n = 60 p
Pre-operative PTH level 47.43 (27; 80) 53.37 (17; 83) NS
Pre-operative calcium level 9.66 (8.9; 10.1) 9.54 (8.9; 10.0) NS
Post-surgical PTH 31.76 (6.8; 70.0) 22.76 (< 2.5; 70) 0.004
6-hours post-surgery calcium level 8.93 (8.8; 9.4) 8.62 (7.9; 9.1) 0.01
PTH on 1st POD 36.57 (17; 80) 27.13 (< 2.5; 70) < 0.001
Calcium level on 1st POD 8.91 (8.8; 9.4) 8.28 (7.0; 8.9) < 0.001
PTH on 14th POD 43.4 (21; 70) 40.2 (< 2.5; 82) NS
Calcium level on 14th POD 9.46 (8.9; 10.2) 9.39 (7.9; 10.0) NS
Post-surgical PTH decrease 35.12 59.39 0.003
PTH decrease on the 1st POD 22.47 50.29 < 0.001
NS: non-significant; PTH: parathyroid hormone; POD: post-operative days. The values shown correspond to the average values obtained from the 100 patients in the study, as well as 
the minimum and maximum values in each group; PTH (pg/mL); Blood calcium (mg/dL).
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only three patients presented with HPC on the 14th day 
determination and needed to maintain a calcium and vitamin 
D supplementation (Fig. 1). The presence of parathyroid 
glands in the pathological examination of thyroidectomy 
surgical samples was found in these three patient (Table 2).
 Only three NC patients (n = 40) presented with PTH 
levels below 9 pg/mL on the immediate post-surgical 
determination and were normal on the first POD. None of 
these patients had PTH levels below the normal range on 
the 14th POD (Fig 1, 2 and 3). 
 When comparing PTH decrease between both groups, 
we found that these were higher in the HPC group, more 
significantly as regards the values obtained on the first day 
upon surgery (50.29% vs. 22.47% - p < 0.001 ) (Table 3). 
 The ROC curves regarding the absolute value of PTH0, 
PTH1, PTH0 decrease and PTH1 decrease showed that 
only the PTH1 decrease curve had an AUC (0.853) allowing 
for a good predictive power (Fig. 4 and 5).
 The best HPC predictive factor (best relationship 
between sensitivity and specificity) upon analysing the 
ROC curves was a PTH1 reduction with an area above the 
ROC curve  above 19.4% (sensitivity = 83% and specificity 
= 63%). The post-operative PTH absolute value (PTH0 
or PTH1), according to our analysis, did not show a good 
predictive value (AUC of 0.669 and 0,649, respectively). 
 The impact of pre-operative diagnosis (benign vs. 
malignant), surgeon’s experience (specialist vs. resident) 
and the number of parathyroid glands found during surgery 
(≤ 2 vs. > 2 glands) on HPC’s incidence was also analysed. 
No statistically significant differences were found (p = 0.22, 
p = 0.515 and p = 0.28 respectively). 
DISCUSSION
 The importance of parathyroid glands and their 
vulnerability during thyroid’s surgery has been recognized 
since the end of the XIX century. When all parathyroid 
glands are put at risk, as in total or remnant thyroidectomy, 
patients may develop transitory or permanent HPT with 
HPC. Despite a careful and thorough surgical technique, 
parathyroid glands may be removed or de-vascularized 
during surgery.15,16 This is even more serious with non-
negligible frequent anatomical variations, namely an ectopic, 
subcapsular or intra-thyroid location. The incidence of post-
thyroidectomy temporary or permanent HPC is considerably 
variable and may reach high percentage (20 – 50%).2-4,10,11,22-
29 Its real incidence may be underestimated as prophylactic 
calcium administration is a common practice in many 
healthcare centres for all patients, in order to allow for early 
hospital discharges.1 Despite this variability in incidence, 
HPC is  the most usual complication upon thyroidectomy1,17 
and one the main reasons for the long hospital stay of 
these patients. As it is not an immediate manifestation (it 
usually occurs 24-48 hours upon surgery)2,22-27 clinical and 
analytical monitoring is required, increasing the hospital 
 
Figure 1 – Distribution of the 100 patients according to PTH values 
obtained on the 14th post-operative day
 
Figure 2 – Distribution of the 100 patients according to PTH level 
determination obtained on the 1st post-operative day
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Figure 3 – Distribution of the 100 patients according to PTH level 
determination obtained upon surgery
80.0 80.0
60.0 60.0
40.0 40.0
20.0 20.0
9 pg/mL 9 pg/mL
0.0
5.0 5.010.0 10.0
Normocalcaemia
n = 40
Number of patients
PT
H
 u
po
n 
su
rg
er
y 
(p
g/
m
L)
PTH
 upon surgery (pg/m
L)
Hypocalcaemia
n = 60
15.0 15.0
A
R
TIG
O
 O
R
IG
IN
A
L
326Revista Científica da Ordem dos Médicos          www.actamedicaportuguesa.com                                                                                                                
 
Figure 4 – ROC-curves regarding the absolute values of PTH levels 
obtained upon surgery and on the 1st POD
 
Figure 5 – ROC-curves regarding PTH level decrease after surgery 
and on the 1st POD
stay. As costs of each hospital day are significant to hospital 
budgets, the use of procedures allowing for early and safe 
clinical discharges become an important contribution to the 
aim of the current study. 
 Our study showed a high incidence of HPC – 60%. 
However, only 14 from the 100 patients involved in the study 
presented with symptomatic HPC and the need for calcium 
and vitamin D supplementation during the hospital stay and 
upon discharge. The clinical and analytical control carried 
out on the 14th POD showed that only three patients still had 
HPC secondary to HPT, those in whom oral calcium and 
vitamin D therapy were maintained. The first-year follow-
up of these three patients showed the persistence of HPC 
and HPT, corresponding to a 3% rate of definitive HPC/HPT, 
close to the values obtained in other clinical series.3,4
 The phosphate and magnesium monitoring taken 
simultaneously with calcium levels was not relevant in 
our study. The phosphate levels followed an expected 
progression, i.e. increased in the patients with HPC and 
normalized when calcium returned back to normal. The 
magnesium levels were maintained within the normal range 
in all the patients and therefore did not influence the calcium 
levels.
 The average global time of hospital stay was 2.67 POD, 
longer in HPC patients (2.93 POD vs. 2.27 POD in NC 
patients), mainly when HPC was symptomatic (4.21 POD 
in patients with symptomatic HPC). These data support the 
importance of HPC in estimating the time of hospital stay of 
patients who undergo total/remnant thyroidectomy.22,23,26
 Some authors recommend the prophylactic 
supplementation with calcium and vitamin D in all patients 
submitted to total or remnant thyroidectomy, in order to 
insure early and safe hospital discharges.8,13 Despite being 
a safe strategy with a good cost-benefit relationship, as 
shown in the study by Michel Singer et al.,13 some experts 
raised concerns regarding the high number of patients who 
are unnecessarily treated and therefore exposed to the 
risk, even theoretical, of constipation, kidney stones and 
changes in iron and zinc absorption.1,13
 Recommendations differ as regards the use of PTH 
determinations as HPC predictive, allowing for the 
identification of patients at higher risk of HPC, who require 
prophylactic treatment with calcium, aiming for early and 
safe discharge1,2,9-12,22-29 This strategy is based on the fact 
that transitory or definitive HPT is the major factor for HPC 
after thyroidectomy, as shown in the study by Lindblom et 
al.12
 Several studies with different protocols have been 
published but all aimed to assess PTH as predictive factor of 
HPC upon thyroidectomy. The timing of PTH measurements 
varies between the studies. Those  by Grodski and Serpell 
found that PTH determination may be obtained at any 
moment from 10 minutes to several hours upon surgery, 
with results similarly accurate for predicting  HPC (Level C 
recommendation).2,3
 Our study aimed to assess the predictive power of PTH 
concentration or its reduction to predict HPC upon total or 
remnant thyroidectomy, as well as to determine the most 
efficient or predictive timing for the assay. In our analysis we 
were not able to determine an absolute PTH value, with a 
good HPC predictive power, both immediately post-surgery 
or on the first POD. This was related to the variability in PTH 
levels in the group of HPC patients. However, we found that 
a PTH reduction above 19.4% is a good HPC predictive 
factor upon total or remnant thyroidectomy, especially when 
obtained on the first day after surgery (area under the ROC 
curve 0.853 – Sensitivity = 82% and Specificity = 63%). We 
believe that a larger group of patients would allow for an 
improvement in sensitivity and specificity of the value of 
PTH decrease, as well as for establishing an absolute PTH 
level predictive of HPC.
 Published studies have shown a relationship between 
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a lower morbidity after thyroidectomy, according to the 
surgeon’s expertise and specialized training.14 However, we 
were not able to find any statistically significant differences 
in HPC’s incidence between patients operated by a 
specialist vs. a resident general surgeon. We should point 
out that in our centre, although the main surgeon in several 
surgeries was a resident and therefore with lower surgical 
experience, he was always supervised and actively assisted 
by an experienced surgeon, which may have explained this 
unexpected result.
 We found several factors associated to a higher risk 
of HPC as previously described. Two factors frequently 
identified are a pre-operative diagnosis of malignancy 
and the number of parathyroid glands identified during 
surgery.19-21 These factors had no influence in the incidence 
of HPC in our study.
CONCLUSION
 PTH determination in patients submitted to total or 
remnant thyroidectomy, especially the value of PTH 
reduction observed on the first day upon surgery plays a 
useful role as it allows for the identification of patients at a 
higher risk of HPC, for prophylactic treatment and for early 
and safe discharge thereby reducing a patient’s hospital 
stay.
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